Clinical Outcomes and Disease Progression among Patients Coinfected with HIV and Human T Lymphotropic Virus Types 1 and 2

Beilke, Mark A.; Theall, Katherine P.; O'Brien, Megan; Clayton, John L.; Benjamin, Stephanie M.; Winsor, Eisa L.; Kissinger, Patricia J.
July 2004
Clinical Infectious Diseases;7/15/2004, Vol. 39 Issue 2, p256
Academic Journal
The goal of this study was to investigate clinical outcomes and survival probabilities among persons coinfected with human immunodeficiency virus (HIV) and human T lymphotropic viruses types 1 and 2 (HTLV-I/II). A nonconcurrent cohort study of 1033 HIV-infected individuals was also conducted. Sixty-two patients were coinfected with HTLV-I, and 141 patients were coinfected with HTLV-II. HTLV-I/II coinfection was highly associated with African-American race/ethnicity, age of >36 years, higher CD4+ T cell count at baseline and over time, and history of injection drug use. Coinfected patients were more likely to have neurologic complications, thrombocytopenia, respiratory and urinary tract infections, and hepatitis C. Despite having higher CD4+ T cell counts over time, there was no difference in the incidence of opportunistic infections. Progression to both acquired immunodeficiency syndrome (AIDS; adjusted hazard ratio [aHR], 0.50; 95% confidence interval [CI], 0.25-0.98) and death (aHR, 0.57, 95% CI, 0.37-0.89) were slower among HTLV-II-coinfected patients, compared with time-entry- and CD4+ T cell count-matched control subjects. In conclusion, HIV- HTLV-I/II coinfection may result in improved survival and delayed progression to AIDS, but this happens at the expense of an increased frequency of other of clinical complications.


Related Articles

  • Papular pruritic eruptions: A marker of progressive. Samanta, Moumita; Kundu, Chanchal; Sarkar, Mihir; Bhattacharyya, Subhashish; Chatterjee51, Sukanta // Indian Journal of Sexually Transmitted Diseases;2009, Vol. 30 Issue 2, p79 

    Context: Papular pruritic eruptions (PPEs) are a commonly seen dermatological manifestation in children with Human Immunodeficiency Virus (HIV) stage 2 disease, whereas recurrent upper respiratory tract infection (URTI) (>2 episodes in 6 months) is the most common presenting illness in this...

  • Platelets: Envoys at the Infection Frontline. Gardiner, Elizabeth E.; Andrews, Robert K. // Journal of Infectious Diseases;Sep2013, Vol. 208 Issue 6, p871 

    The authors focus on a pre-clinical study, which evaluates the role of the frontline defensive duties of platelets and progression of platelet depletion in human immunodeficiency virus (HIV) infection by using a simian immunodeficiency virus (SIV) in a macaque model. They inform that platelets...

  • HIV-1 & -2 Co-Infections with Multi-Drug Resistant (MDR) Uropathogens in Port Harcourt, Nigeria. Frank-Peterside, N.; Chukwugozim-Umejuru, R.; Okerentugba, P. O.; Okonko, I. O. // Nature & Science;2013, Vol. 11 Issue 11, p11 

    This study was carried out to detect the presence of HIV-1 & -2 coinfections with MDR uropathogens among patients in Port Harcourt, Nigeria. Determine® HIV-1/2, HIV -1/2 Stat- Pak® Assay and Bi-Spot HIV-1 & 2 ImmunoConfirm test kits were used for the detection of HIV-1 and HIV-2 in serum...

  • ADVISER. Califia, Pat // Advocate;3/12/91, Issue 572, CLASSIFIEDS p68 

    Responds to questions on topics of interest to gays and lesbians. Prevention of urinary tract infections; Female impersonation; Comments that people make about HIV-positive persons.

  • T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Hazenberg, Mette D.; Hamann, Dörte; Schuitemaker, Hanneke; Miedema, Frank // Nature Immunology;Oct2000, Vol. 1 Issue 4, p285 

    HIV-1 infection is characterized by a gradual loss of CD4+ T cells and progressive immune deficiency that leads to opportunistic infections, otherwise rare malignancies and ultimately death. Extensive research over the past two decades has increased our insight into the pathogenic mechanisms...

  • HIV Infection Increases the Risk of Heparin-Induced Thrombocytopenia. Thompson III, George R.; Lawrence, Valerie A.; Crawford, George E. // Clinical Infectious Diseases;11/15/2007, Vol. 45 Issue 10, p1393 

    The incidence of heparin-induced thrombocytopenia in human immunodeficiency virus (HIV)-infected inpatients was compared with that in a control group that was not known to be infected with HIV in a retrospective cohort study. HIVinfected patients receiving heparin therapy, especially...

  • Gastrointestinal complications of HIV infection: changing priorities in the HAART era. Wilcox, C. M.; Saag, M. S. // Gut;Jun2008, Vol. 57 Issue 6, p861 

    It has now been some 25 years since the initial description of AIDS. Following these observations, the epidemiology, natural history and manifestations of this disease have been well characterised. Intense investigation has better characterised HIV, resulting in the development of effective drug...

  • Multiple myeloma as the first manifestation of acquired immunodeficiency syndrome: a case report and review of the literature. Pouli, A.; Lemessiou, H.; Rontogianni, D.; Papanastassiou, C.; Tsakanikas, S.; Gerassimou, A.; Stamatelou, M. // Annals of Hematology;Sep2001, Vol. 80 Issue 9, p557 

    Various hematologic malignancies and solid tumors are increasingly diagnosed in patients with human immunodeficiency virus (HIV) infection and may be the presenting manifestation of acquired immunodeficiency syndrome (AIDS). Multiple myeloma, however, has never been reported as the presenting...

  • Minerva.  // BMJ: British Medical Journal (International Edition);8/7/2004, Vol. 329 Issue 7461, p358 

    Presents medical news briefs. Study which finds that treatment of urinary tract infections in women will improve with a longer course of medication; Study on a link between cell phone usage and salivary gland tumours where no connection could be determined; Indian study which suggests that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics